Deficiency of Kallikrein Activity in Plasma of Patients with Cystic Fibrosis
- 18 August 1972
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 177 (4049), 610-611
- https://doi.org/10.1126/science.177.4049.610
Abstract
Total kallikrein activity and kallikrein activity inhibited by soybean trypsin inhibitor are significantly reduced in the plasma of patients with cystic fibrosis compared to age-matched controls. The level of the STI inhibited kallikrein activity in the plasma of heterozygotes was significantly different from that in either controls or affected children. However, the individual heterozygote could not be reliably identified in each case.Keywords
This publication has 10 references indexed in Scilit:
- Deficiency of trypsin-like activity in saliva of patients with cystic fibrosisThe Journal of Pediatrics, 1972
- Kallikreins and kinins.Physiological Reviews, 1969
- Oyster Ciliary Inhibition by Cystic Fibrosis FactorScience, 1969
- Studies on the prekallikrein (kallikreinogen)—kallikrein enzyme system of human plasmaJCI Insight, 1969
- Studies on the Mechanism of Inhibition of Sodium Transport in Cystic Fibrosis of the PancreasPediatric Research, 1968
- Pathogenesis and Physiopathology of Cystic Fibrosis of the PancreasNew England Journal of Medicine, 1967
- Pathogenesis and Physiopathology of Cystic Fibrosis of the PancreasNew England Journal of Medicine, 1967
- Pathogenesis and Physiopathology of Cystic Fibrosis of the PancreasNew England Journal of Medicine, 1967
- Abnormal Serum Factor in Patients with Cystic Fibrosis of the PancreasPediatric Research, 1967
- Investigation of serum trypsin and related substancesArchives of Biochemistry and Biophysics, 1962